These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15122326)

  • 1. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Oeggerli M; Tomovska S; Schraml P; Calvano-Forte D; Schafroth S; Simon R; Gasser T; Mihatsch MJ; Sauter G
    Oncogene; 2004 Jul; 23(33):5616-23. PubMed ID: 15122326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Zheng M; Simon R; Mirlacher M; Maurer R; Gasser T; Forster T; Diener PA; Mihatsch MJ; Sauter G; Schraml P
    Am J Pathol; 2004 Jul; 165(1):63-9. PubMed ID: 15215162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
    Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and overexpression of E2F3 in human bladder cancer.
    Feber A; Clark J; Goodwin G; Dodson AR; Smith PH; Fletcher A; Edwards S; Flohr P; Falconer A; Roe T; Kovacs G; Dennis N; Fisher C; Wooster R; Huddart R; Foster CS; Cooper CS
    Oncogene; 2004 Feb; 23(8):1627-30. PubMed ID: 14716298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
    Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
    Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.
    Choschzick M; Lebeau A; Marx AH; Tharun L; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Simon R; Sauter G; Schwarz J
    Hum Pathol; 2010 Mar; 41(3):358-65. PubMed ID: 19896697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications.
    Krüger S; Lange I; Kausch I; Feller AC
    Anticancer Res; 2005; 25(1A):263-71. PubMed ID: 15816547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
    Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
    Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer.
    Sauter G; Moch H; Gasser TC; Mihatsch MJ; Waldman FM
    Cytometry; 1995 Sep; 21(1):40-6. PubMed ID: 8529469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.
    Simon R; Richter J; Wagner U; Fijan A; Bruderer J; Schmid U; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Anabitarte M; Hering F; Hardmeier T; Schönenberger A; Flury R; Jäger P; Fehr JL; Schraml P; Moch H; Mihatsch MJ; Gasser T; Sauter G
    Cancer Res; 2001 Jun; 61(11):4514-9. PubMed ID: 11389083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
    Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
    Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
    Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.
    Ohta JI; Miyoshi Y; Uemura H; Fujinami K; Mikata K; Hosaka M; Tokita Y; Kubota Y
    Clin Cancer Res; 2001 Aug; 7(8):2463-7. PubMed ID: 11489827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
    Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.
    Wild PJ; Kunz-Schughart LA; Stoehr R; Burger M; Blaszyk H; Simon R; Gasser T; Mihatsch M; Sauter G; Hartmann A
    Int J Oncol; 2005 Aug; 27(2):385-91. PubMed ID: 16010419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.